Psyence Biomedical (PBM) Stock Statistics & Valuation Metrics

Psyence Biomedical has a market cap or net worth of $19.68M. The enterprise value is -$6.08T.

Psyence Biomedical has 3,814,328 shares outstanding. The number of shares has decreased by -2.65% in one year.

Psyence Biomedical’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -36.81%.

The current PE Ratio of Psyence Biomedical is ―. Psyence Biomedical’s PEG ratio is 0.00024.

In the last 12 months, Psyence Biomedical had revenue of 0.00 and earned -6.94M in profits. Earnings per share was -12.56.

In the last 12 months, operating cash flow was -1.05M and capital expenditures -8.00, giving a free cash flow of -1.05M billion.

Psyence Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Psyence Biomedical upcoming earnings date is ―, ―.

Psyence Biomedical as a current ratio of 14.62, with Debt / Equity ratio of 0.00%

In the past 12 months, Psyence Biomedical has paid 0.00 in taxes.

Psyence Biomedical EV to EBITDA ratio is 0.88, with an EV/FCF ratio of 0.70.

Psyence Biomedical has $733.00 in cash and marketable securities with $10.45K in debt, giving a net cash position of -$9.71K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Psyence Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―